Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-17-003985
Filing Date
2017-08-08
Accepted
2017-08-08 17:30:35
Documents
40
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ohrp-10q_063017.htm 10-Q 456847
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER ex31-1.htm EX-31.1 11924
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER ex31-2.htm EX-31.2 11610
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER ex32-1.htm EX-32.1 4592
5 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER ex32-2.htm EX-32.2 4615
  Complete submission text file 0001387131-17-003985.txt   1747054

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ohrp-20170630.xml EX-101.INS 197766
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ohrp-20170630.xsd EX-101.SCH 17019
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ohrp-20170630_cal.xml EX-101.CAL 33182
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ohrp-20170630_def.xml EX-101.DEF 71422
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ohrp-20170630_lab.xml EX-101.LAB 168881
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ohrp-20170630_pre.xml EX-101.PRE 132525
Mailing Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022
Business Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022 (212) 682-8452
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

EIN.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35963 | Film No.: 171015809
SIC: 2834 Pharmaceutical Preparations